Previous consultations on derogation to the exclusion criteria

The closed consultations on the derogations to the exclusion criteria as laid down in Article 5(2) of the BPR are listed in the table below. 

Current consultations

There are currently no ongoing consultations.
 
2,2-dibromo-2-cyanoacetamide; [DBNPA] 4 233-539-7 10222-01-2 11/10/2019 10/12/2019
Cholecalciferol 14 200-673-2 67-97-0 01/02/2018 01/04/2018
Creosote PT08 232-287-5 8001-58-9 29/01/2021 30/03/2021
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 1:1) (originally notified as HPT) 2, 6, 11, 13 - - 04/09/2017 04/11/2017
Reaction products of paraformaldehyde and 2- hydroxypropylamine (ratio 3:2) (originally notified as MBO) 2, 6, 11, 12, 13 - - 04/09/2017 04/11/2017